[150] Skinner‐Adams TS, Andrews KT, Melville L, McCarthy J, Gardiner DL. Synergistic
interactions of the antiretroviral protease inhibitors saquinavir and ritonavir with chlo‐
roquine and mefloquine against Plasmodium falciparum in vitro. Antimicrobial Agents
and Chemotherapy. 2007; 51 (2):759‐762. doi:10.1128/AAC.00840‐06
[151] Hobbs CV, Voza T, Coppi A, Kirmse B, Marsh K, Borkowsky W, et al.. HIV prote‐
ase inhibitors inhibit the development of preerythrocytic‐stage plasmodium parasites.
Journal of Infectious Diseases. 2009; 199 (1):134‐141. doi:10.1086/594369
[152] Liu K, Shi H, Xiao H, Chong AG, Bi X, Chang YT, et al. Functional profiling, identifica‐
tion, and inhibition of plasmepsins in intraerythrocytic malaria parasites. Angewandte
Chemie International Edition in English. 2009; 48 (44):8293‐8297. doi:10.1002/
anie.200903747
[153] Bonilla JA, Moura PA, Bonilla TD, Yowell CA, Fidock DA, Dame JB. Effects on
growth, hemoglobin metabolism and paralogous gene expression resulting from
disruption of genes encoding the digestive vacuole plasmepsins of Plasmodium fal‐
ciparum. International Journal for Parasitology. 2007; 37 (3‐4):317‐327. doi:10.1016/j.
ijpara.2006.11.008
[154] Omara‐Opyene AL, Moura PA, Sulsona CR, Bonilla JA, Yowell CA, Fujioka H, et
al.. Genetic disruption of the Plasmodium falciparum digestive vacuole plasmepsins
demonstrates their functional redundancy. The Journal of Biological Chemistry.
2004; 279 (52):54088‐54096. doi:10.1074/jbc.M409605200
[155] Bonilla JA, Bonilla TD, Yowell CA, Fujioka H, Dame JB. Critical roles for the diges‐
tive vacuole plasmepsins of Plasmodium falciparum in vacuolar function. Molecular
Microbiology. 2007; 65 (1):64‐75. doi:10.1111/j.1365‐2958.2007.05768.x
[156] Liu J, Gluzman IY, Drew ME, Goldberg DE. The role of Plasmodium falciparum food
vacuole plasmepsins. The Journal of Biological Chemistry. 2005; 280 (2):1432‐1437.
doi:10.1074/jbc.M409740200
[157] Liu J, Istvan ES, Gluzman IY, Gross J, Goldberg DE. Plasmodium falciparum ensures
its amino acid supply with multiple acquisition pathways and redundant proteolytic
enzyme systems. Proceedings of the National Academy of Sciences of the United States
of America. 2006; 103 (23):8840‐8845. doi:10.1073/pnas.0601876103
[158] Parikh S, Gut J, Istvan E, Goldberg DE, Havlir DV, Rosenthal PJ. Antimalarial activity of
human immunodeficiency virus type 1 protease inhibitors. Antimicrobial Agents and
Chemotherapy. 2005; 49 (7):2983‐2985. doi:10.1128/AAC.49.7.2983‐2985.2005
[159] Ersmark K, Feierberg I, Bjelic S, Hamelink E, Hackett F, Blackman MJ, et al. Potent
inhibitors of the Plasmodium falciparum enzymes plasmepsin I and II devoid of cathepsin
D inhibitory activity. Journal of Medicinal Chemistry. 2004; 47 (1):110‐122. doi:10.1021/
jm030933g
Plasmepsin: Function, Characterization and Targeted Antimalarial 'rug 'evelopment
http://dx.doi.org/10.5772/66716217